Does Saltikva have Fast Track designation, and when was it granted?

Yes. The FDA granted Fast Track designation for stage IV pancreatic cancer in 2022 (Orphan Drug Designation was granted in May 2022). The FDA does not publish Fast Track grants. A Fast Track designation is a process designation and does not indicate that a product is approved or effective.